EISAI-BAN2401-G000-201

Study Sponsor: Eisai

Study Title

A Placebo-Controlled, Double-Blind, Parallel-Group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study With an Open-Label Extension Phase to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

Medicine or Vaccine (generic name)

lecanemab

Sponsor Identification Number

BAN2401-G000-201

Trial Registry Identification Number(#'s)

NCT01767311

Medical Condition

Alzheimer's disease

Phase

Phase 2

Link to study details on the Eisai Clinical Study Register

not available

Link to study details on ClinicalTrials.gov (if available)

https://clinicaltrials.gov/study/NCT01767311

Link to study details on EudraCT (if available)

EudraCT Number 2012-002843-11 - Clinical trial results - EU Clinical Trials Register

Datasets and Documents Available for this Study

Additional information about the data and documents available for this study

MRI images cannot be shared.

Date Added to this Site

March 2026